Efficacy of higher-dose levamisole in maintaining remission in steroid-dependant nephrotic syndrome. 2017

Asiri S Abeyagunawardena, and Umeshi Karunadasa, and Heshan Jayaweera, and Shenal Thalgahagoda, and Sampath Tennakoon, and Shamali Abeyagunawardena
Department of Paediatrics, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka. asiriabey26@gmail.com.

OBJECTIVE Levamisole (LEV) has been used successfully on an alternate-day regime of 2.5 mg/kg in steroid-dependant nephrotic syndrome (SDNS) to maintain remission. This pilot study was carried out between 2010 and 2015 at a single center in Sri Lanka to evaluate the efficacy of LEV prescribed at 2.5 mg/kg daily, which is double the alternate-day dose. METHODS Sequential children with SDNS, relapsing more than twice in the preceding 12 months and previously treated with LEV and low-dose alternate-day prednisolone (0.1-0.6 mg/kg) were recruited to the study. This group received LEV (2.5 mg/kg) daily with the same dose of alternate-day prednisolone for 1 year. Urine protein excretion was recorded by parents on a daily basis, and the presence of 3+ proteinuria on 3 consecutive days was considered a relapse. Full blood counts and liver function tests were performed every 3 months to monitor for adverse effects. RESULTS Sixty-four children were enrolled into the study; six were excluded due to prescription of other immunosuppressive drugs. Median age was 7.9 years; 33 were boys. The number of relapse episodes was 163 [mean per patient 2.8 ± standard deviation (SD) 0.8] in patients on alternate-day LEV and 77 (mean 1.3 ± SD 0.9) for those on daily LEV during the 12-month period of observation. The P value 0.000 (according to the Wilcoxon signed-rank test) was <0.001. No major adverse events were noted. CONCLUSIONS The prescription of daily LEV is effective and safe for maintaining SDNS remission.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007978 Levamisole An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6) L-Tetramisole,Levotetramisole,Decaris,Dekaris,Levamisole Hydrochloride,Solaskil,Hydrochloride, Levamisole
D008111 Liver Function Tests Blood tests that are used to evaluate how well a patient's liver is working and also to help diagnose liver conditions. Function Test, Liver,Function Tests, Liver,Liver Function Test,Test, Liver Function,Tests, Liver Function
D008297 Male Males
D009404 Nephrotic Syndrome A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction. Childhood Idiopathic Nephrotic Syndrome,Frequently Relapsing Nephrotic Syndrome,Multi-Drug Resistant Nephrotic Syndrome,Pediatric Idiopathic Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndrome,Steroid-Resistant Nephrotic Syndrome,Steroid-Sensitive Nephrotic Syndrome,Multi Drug Resistant Nephrotic Syndrome,Nephrotic Syndrome, Steroid-Dependent,Nephrotic Syndrome, Steroid-Resistant,Nephrotic Syndrome, Steroid-Sensitive,Nephrotic Syndromes,Steroid Dependent Nephrotic Syndrome,Steroid Resistant Nephrotic Syndrome,Steroid Sensitive Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndromes,Steroid-Resistant Nephrotic Syndromes,Steroid-Sensitive Nephrotic Syndromes,Syndrome, Nephrotic,Syndrome, Steroid-Sensitive Nephrotic
D009503 Neutropenia A decrease in the number of NEUTROPHILS found in the blood. Neutropenias
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D010865 Pilot Projects Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. Pilot Studies,Pilot Study,Pilot Project,Project, Pilot,Projects, Pilot,Studies, Pilot,Study, Pilot
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF

Related Publications

Asiri S Abeyagunawardena, and Umeshi Karunadasa, and Heshan Jayaweera, and Shenal Thalgahagoda, and Sampath Tennakoon, and Shamali Abeyagunawardena
January 1994, Nephron,
Asiri S Abeyagunawardena, and Umeshi Karunadasa, and Heshan Jayaweera, and Shenal Thalgahagoda, and Sampath Tennakoon, and Shamali Abeyagunawardena
September 2002, Saudi medical journal,
Asiri S Abeyagunawardena, and Umeshi Karunadasa, and Heshan Jayaweera, and Shenal Thalgahagoda, and Sampath Tennakoon, and Shamali Abeyagunawardena
October 2010, Iranian journal of kidney diseases,
Asiri S Abeyagunawardena, and Umeshi Karunadasa, and Heshan Jayaweera, and Shenal Thalgahagoda, and Sampath Tennakoon, and Shamali Abeyagunawardena
May 2014, Indian pediatrics,
Asiri S Abeyagunawardena, and Umeshi Karunadasa, and Heshan Jayaweera, and Shenal Thalgahagoda, and Sampath Tennakoon, and Shamali Abeyagunawardena
August 1998, Pediatric nephrology (Berlin, Germany),
Asiri S Abeyagunawardena, and Umeshi Karunadasa, and Heshan Jayaweera, and Shenal Thalgahagoda, and Sampath Tennakoon, and Shamali Abeyagunawardena
August 2013, International urology and nephrology,
Asiri S Abeyagunawardena, and Umeshi Karunadasa, and Heshan Jayaweera, and Shenal Thalgahagoda, and Sampath Tennakoon, and Shamali Abeyagunawardena
October 2017, Indian pediatrics,
Asiri S Abeyagunawardena, and Umeshi Karunadasa, and Heshan Jayaweera, and Shenal Thalgahagoda, and Sampath Tennakoon, and Shamali Abeyagunawardena
January 2006, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP,
Asiri S Abeyagunawardena, and Umeshi Karunadasa, and Heshan Jayaweera, and Shenal Thalgahagoda, and Sampath Tennakoon, and Shamali Abeyagunawardena
January 2019, Indian journal of nephrology,
Asiri S Abeyagunawardena, and Umeshi Karunadasa, and Heshan Jayaweera, and Shenal Thalgahagoda, and Sampath Tennakoon, and Shamali Abeyagunawardena
February 2006, Pediatric nephrology (Berlin, Germany),
Copied contents to your clipboard!